Source - LSE Regulatory
RNS Number : 6461O
Intl. Biotechnology Trust PLC
02 February 2023
INTERNATIONAL BIOTECHNOLOGY TRUST PLC
("IBT" or the "Company")
Portfolio Update as at 1 February 2023
The Company notes that there has been a material adjustment to the valuation of an investment from the unquoted portfolio managed by SV Health Managers LLP in which the Company is invested.
The net asset value of the Company will therefore increase by £2.9m ($3.6m) which corresponds to 7p per share uplift and will be incorporated into today's unaudited net asset value (calculated on the AIC basis
For further information contact:
Company Secretary - Link Company Matters
Indu Shastri +44 (0)7936 045789
LEI: 213800N1QUJ744P76D11
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
